⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10950932 | 1.00 | — | — | |
| SCHEMBL8580870 | 1.00 | — | — | |
| SCHEMBL43120 | 1.00 | — | — | |
| SCHEMBL89217 | 1.00 | — | — | |
| SCHEMBL8760908 | 0.82 | — | — | |
| SCHEMBL11208722 | 0.82 | — | — | |
| SCHEMBL949706 | 0.82 | — | — | |
| SCHEMBL3752989 | 0.82 | — | — | |
| SCHEMBL8762021 | 0.82 | — | — | |
| Fluoride SCHEMBL8778147 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 239 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12478710-B2 | Embolic compositions and methods | ARSENAL MEDICAL, INC. (US) | 2025-11-25 | — | — | US | claimed |
| US-20230218798-A1 | EMBOLIC COMPOSITIONS AND METHODS | ARSENAL MEDICAL, INC. | 2023-07-13 | — | — | US | claimed |
| EP-4161599-A1 | EMBOLIC COMPOSITIONS AND METHODS | Arsenal Medical, Inc. (US) | 2023-04-12 | — | — | EP | claimed |
| CN-115706008-A | Power semiconductor device and method for manufacturing power semiconductor device | 英飞凌科技股份有限公司 | 2023-02-17 | — | — | CN | claimed |
| EP-3750896-B1 | CHIRAL TETRADENTATE LIGAND, METHOD FOR PRODUCING SAME AND TRANSITION METAL COMPLEX OF SAID CHIRAL TETRADENTATE LIGAND | TAKASAGO PERFUMERY CO LTD (JP) | 2022-06-29 | — | — | EP | claimed |
| EP-3927773-A1 | CROSSLINKABLE POLYMER COMPOSITIONS | Arsenal Aaa, LLC (US) | 2021-12-29 | — | — | EP | claimed |
| WO-2021252642-A1 | EMBOLIC COMPOSITIONS AND METHODS | ARSENAL MEDICAL, INC. (US) | 2021-12-16 | — | — | WO | claimed |
| EP-3438113-B1 | TETRADENTATE LIGAND, AND PRODUCTION METHOD THEREFOR, SYNTHETIC INTERMEDIATE THEREOF, AND TRANSITION METAL COMPLEX THEREOF | TAKASAGO PERFUMERY CO LTD (JP) | 2021-02-17 | — | — | EP | claimed |
| EP-3750896-A1 | CHIRAL TETRADENTATE LIGAND, METHOD FOR PRODUCING SAME AND TRANSITION METAL COMPLEX OF SAID CHIRAL TETRADENTATE LIGAND | Takasago International Corporation (JP) | 2020-12-16 | — | — | EP | claimed |
| US-20200369700-A1 | CHIRAL TETRADENTATE LIGAND, METHOD FOR PRODUCING SAME AND TRANSITION METAL COMPLEX OF SAID CHIRAL TETRADENTATE LIGAND | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2020-11-26 | — | — | US | claimed |
| US-7276117-B2 | Method of forming semi-insulating silicon carbide single crystal | CREE DULLES, INC. (US) | 2007-10-02 | — | — | US | claimed |
| EP-1816123-A1 | Intermediates for the production of pharmaceutically active compounds | AstraZeneca AB (SE) | 2007-08-08 | — | — | EP | claimed |
| US-20060211888-A1 | 2,2'-bis-(1-alkylphosphetanes); a primary alkyl or cycloalkyl phosphine is reacted with 1,3-dichloropropane, in the presence of n-butyllithium, and then reacted with boron trihydride, oxygen, or sulfur, dimerizing, removing the boron trihydride, oxygen, or sulfur; assymetric hydrogenation catalysts | NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) | 2006-09-21 | — | — | US | claimed |
| US-20060189818-A1 | Novel optically active phosphorus-chiral diphosphetanes, intermediates of the same, and transition metal complexes containing the diphosphetanes as the ligand | NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) | 2006-08-24 | — | — | US | claimed |
| US-20060174825-A1 | Method of forming semi-insulating silicon carbide single crystal | WOLFSPEED, INC. | 2006-08-10 | — | — | US | claimed |
| EP-1650217-A1 | NOVEL OPTICALLY ACTIVE PHOSPHORUS-CHIRAL DIPHOSPHETANES, INTERMEDIATES OF THE SAME, AND TRANSITION METAL COMPLEXES CONTAINING THE DIPHOSPHETANES AS THE LIGAND | Nippon Chemical Industrial Co., Ltd. (JP) | 2006-04-26 | — | — | EP | claimed |
| EP-1650216-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE DIMER OF PHOSPHORUS HETEROCYCLE | NIPPON CHEMICAL INDUSTRIAL COMPANY LIMITED (JP) | 2006-04-26 | — | — | EP | claimed |
| WO-2003088327-A2 | DEPOSITION OF SILICON LAYERS FOR ACTIVE MATRIX LIQUID CRYSTAL DISPLAYS | APPLIED MATERIALS, INC. (US) | 2003-10-23 | — | — | WO | claimed |
| US-20030189208-A1 | Deposition of silicon layers for active matrix liquid crystal display (AMLCD) applications | APPLIED MATERIALS, INC. | 2003-10-09 | — | — | US | claimed |
| US-5210309-A | Multifunctional synthons as used in the preparation of cascade polymers or unimolecular micelles | UNIVERSITY OF SOUTH FLORIDA (US) | 1993-05-11 | — | — | US | claimed |